Therefore, the upregulation of TET1 in HCT116 colon cancer cells not only suppresses their proliferation but also may improve drug resistance to 5-aza-dC in our system, and the role of the DMNT inhibitor may involve maintaining the expression level of TET1. The gene discussed is TET1; the disease is malignant colon neoplasm.